Artificial Intelligence
Predictive Oncology CEO Letter to Shareholders
EAGAN, Minn., Oct. 06, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is pleased to release the CEO’s letter to the shareholders.
To our valued shareholders,
I know you have watched our stock price decline steadily over the past few weeks. I am writing to assure you that there is a lot of encouraging progress to report – in other words, our company is not in the condition that the stock price might indicate. I want to take this opportunity to review where Predictive Oncology stands as of today.
Our cash burn is stable and trending downward. Our revenues are stable and trending upward. Our available cash is adequate for operations and we have the ability to utilize our equity line of credit, which has a remaining amount of over $10 million.
The best news is in the operational progress in our various divisions. Starting with Skyline Medical, this division is self-supporting from a cash standpoint. Sales of disposables used on previously sold machines more than cover the operating expenses of this division, and we continue to sell new machines on a regular basis, adding to future disposables revenues.
Our Helomics division is coming along handsomely. We have launched a restructured clinical test offering to clinicians for ovarian cancer. The response from oncologists to this re-configured test has been excellent and we expect this effort, as well as our other tests, to be revenue generating by year end and should be able to cover the bulk of Helomics operating expenses going forward. We have made solid progress on the UPMC-Magee Women’s Hospital project and are close to completing our AI-driven models of drug response and patient outcomes. We are also finishing the sequencing of the tumors from the patients involved and have completed the “reach back” for patient outcome data (i.e. including data on what happened to the patient). The Magee Study validates our ability to sequence our tumor inventory as well as to do the reach back for patient outcomes. The acquisition and integration of the newly acquired Quantitative Medicine AI software into Helomics’ existing computer model is a major accomplishment. We have begun discussions with large Pharma companies in an effort to form major, multi-year, multi-target, milestone based strategic partnerships. We hope to make more announcements soon.
Our TumorGenesis division has not been resting on its’ laurels. We will be introducing our Ovarian Cell Line Media at the BIO-Europe Conference. This media will allow researchers to isolate and successfully culture ovarian cancer cells that have previously not been cultured. Under the NCI Prevent Cancer Program, TumorGenesis, Cornell Medical and Helomics will coordinate with and seek funding for this program to help identify the best culture media for the studying of mutations that increase the risk of ovarian and breast cancers as well as other types of cancers. TumorGenesis is registering with the U.S. government as a contractor for developmental work in cancer cell capture and screening of compounds for the prevention and treatment of cancer. TumorGenesis Discovery Kits will also launch at the BIO-Europe conference. These kits will allow researchers to study and tag target cancer cells as well as normal cells often associated with tumors and let pathologists screen approved drug therapies across isolated and properly identified ovarian cancer samples from patients.
Last, but certainly not least, is Soluble Biotech. We have moved this division into a new Research Park located in Birmingham, Alabama. This new facility effectively quadruples our Soluble’s office and research space. This state of the art company provides optimized FDA-approved formulations for vaccines, antibodies and other protein therapeutics in a faster and lower cost basis to its customers. In addition, the company recently purchased and installed a suite of new research equipment that enables protein degradation studies which is a new and substantial line of business for the company. Our investment in new equipment, combined with our proprietary existing equipment, expands the company’s capabilities to include temperature-controlled humidity chamber analysis, temperature-controlled photo-stability analysis, differential scanning calorimetry, viscometry analysis, UV/Vis spectroscopy analysis, High Performance Liquid Chromatography (HPLC), a state-of-the-art automated dynamic laser light scattering system (DLS), free flow particle microscopic analysis, circular dichroism analysis, electron microscopy and high resolution mass spectrometry. Soluble Biotech is also planning to begin the development of an FDA-approved GMP facility to further support pharmaceutical needs. We have already secured a sizable contract and we are bidding on several more. I expect Soluble Biotech to be generating revenues by the end of the year.
As you can see, a lot is happening. Much is occurring under the radar. Much doesn’t make for a press release. However, don’t be discouraged by the lack of “blockbuster” announcements. We are moving forward rapidly and we expect the fourth quarter to be eventful. I will make myself available to shareholders who may wish to speak with me.
Sincerely,
Carl Schwartz CEO Predictive Oncology.
About Predictive Oncology, Inc.
Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. TumorGenesis, Inc. a wholly owned subsidiary specializes in media’s that help cancer cells grow and retain their DNA/RNA and proteomic signatures providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. In addition, TumorGenesis is developing a ‘biomarker discovery’ kit and service for life science, pharmaceutical and biotech companies, and research institutions. Its products are sold on-line as well as through a global distributor; US Biologicals Corporation: http://www.usbio.net. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. The company’s services enhance the drug development process by rapidly optimizing protein solubility and stability. Soluble Biotech brings transformational technology to formulation development for protein-based pharmaceutical and vaccines. In addition, our solubilization & stability technology supports fundamental protein research at academic, pharmaceutical and government laboratories. To learn more, please visit: https://solublebiotech.com.
Cautionary Statement Regarding Forward-Looking Statements
Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading “Risk Factors” in our filings with the SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.
Investor Relations Contact:
Hayden IR
James Carbonara
(646)-755-7412
[email protected]
Artificial Intelligence
vcita Completes Full Rollout of BizAI, the First AI-driven SMB Business Advisor
After months of research and beta testing, BizAI is now available to all vcita customers, bringing the promise of AI within reach for the SMB ecosystem
SEATTLE, May 2, 2024 /PRNewswire/ — vcita, the technology platform designed to serve the needs of SMBs and the organizations that serve them, announced today that it has completed the full rollout of its AI-powered SMB business advisor, BizAI. During beta testing over the last several months, vcita saw the significant success and impact of BizAI, and is now making it available to all SMB users, including SMBs using partner solutions, built on its inTandem platform.
BizAI is different from other generative AI tools as it combines the wide perspectives of the market’s best practices with the deep familiarity with each individual businesses’ successes and failures, bespoke data that it is able to obtain exclusively through vcita. This enables BizAI to identify growth opportunities and diagnose areas for improvement, translating insights into actionable recommendations for immediate implementation. SMBs can use BizAI to build business growth plans, optimize their pricing and product offerings according to their competitors, generate converting marketing assets, analyze staff performance, and more.
“BizAI is a pioneering AI-driven business advisor created specifically for the SMB sector,” said Itzik Levy, CEO and founder at vcita. “BizAI brings the strategic prowess of top-tier consulting into the hands of small business owners, empowering SMBs to navigate their unique challenges with tailored, actionable insights derived from a blend of external data, their own operational metrics, and industry benchmarks. The enthusiastic feedback from our beta testers has been incredibly affirming, and this is only the beginning of what BizAI can deliver.”
A common challenge in the adoption of AI is that SMBs don’t always know where AI might help them so BizAI is integrated into the everyday tasks of the business owner, offering them tailored insights and suggestions with contextual relevance. BizAI is completely embedded within the business management solution offered by vcita, with many touch points that are presented to SMBs throughout their workday. For example, SMBs will be prompted to use BizAI when creating and pricing a new service, while writing their cancellation policy, or when answering an inquiry from a promising prospect.
“Our roadmap is packed with plans to further expand BizAI and make it available across all components of our platform. As a platform company, we will soon offer our partners the opportunity to leverage BizAI in two additional ways: the first is their ability to launch AI-enriched applications of their own, and the second is to draw AI-driven insights that help them better understand their SMB clients, detect risks such as churn and identify new business opportunities in real-time,” continued Levy.
A recent survey of BizAI beta users highlights the value they’re gaining from the tool with 43% returning to BizAI within a week of their first usage. 63% used BizAI to seek critical business advice, such as how to position and price their services and products, highlighting the trust users have in BizAI. 32% of users copied the chat’s answers to the clipboard, indicating they were happy with the output and chose to use it. To see a full report with this data please click here.
vcita has spent the past 13 years providing SMBs with advanced technology solutions and is committed to digital inclusion in the SMB community. vcita’s technology solutions include popular digital tools like online billing, CRM, online scheduling, marketing, and online presence, and the company is now bringing the promise of AI within reach for small businesses. Armed with BizAI’s personalized insights and recommendations, vcita is revolutionizing the way SMBs manage their operations and seize growth opportunities within a competitive market. With inTandem, vcita’s partner platform, organizations that serve the SMB market can join vcita’s partner ecosystem and expand their own SMB proposition to include these digital tools and AI driven insights, increase engagement among their SMB customers, and unlock new revenue potential.
About vcita
vcita is an SMB tech company dedicated to helping small and medium businesses thrive in today’s digital world by providing them with the tools to manage and grow their business. With vcita’s solution, small businesses can manage all aspects of their day-to-day operations and client engagement including scheduling, billing, payment collection, client management, email and SMS marketing. inTandem by vcita is a platform designed to serve the needs of SMB service providers, offering a customizable, white-label, platform that allows organizations that serve SMBs to bring their clients all the essential vcita tools under their own brand. With inTandem, partners can deliver great service and value to their SMB customers and unlock new revenue streams, reduce churn, and increase customer loyalty. With hundreds of thousands of small business users worldwide and partnerships including marketing agencies, banks, financial service providers, telcos, MSPs, and fintechs, vcita delivers an innovative digital solution uniquely designed to serve the needs of SMBs and the companies that support them.
For more information, visit www.vcita.com or follow us on LinkedIn.
Media Contact
Sarah SchlossHeadline Media [email protected] 914.506.5105
View original content:https://www.prnewswire.co.uk/news-releases/vcita-completes-full-rollout-of-bizai-the-first-ai-driven-smb-business-advisor-302134563.html
Artificial Intelligence
Stamus Networks Recognized in 2024 Gartner® Market Guide for Network Detection and Response
Company recognized as a Representative Vendor for the second consecutive time
INDIANAPOLIS and PARIS, May 2, 2024 /PRNewswire/ — Stamus Networks, a global provider of high-performance network-based threat detection and response (NDR) systems, today announced it has been recognized as a Representative Vendor in the 2024 Gartner “Market Guide for Network Detection and Response.” This is the second consecutive time Stamus Networks has been named in the report.
“For now, stand-alone NDR vendors provide a breadth of network analytics and efficacy not available with multifunction security platforms (SIEM, XDR),” wrote Gartner Analysts Jeremy D’Hoinne, Thomas Lintemuth, Nahim Fazal and Charanpal Bhogal.
The report continues, “NDR providers continue to improve their detection capabilities and improve incident response workflows, highlighting the identified root causes of an incident. With this success and confidence, enterprises are experimenting with new NDR features and expanding their coverage to include areas of the network not initially exposed to NDR, especially to see all lateral movement between different types of infrastructure.”
The Stamus Security Platform (SSP) is an open NDR that delivers actionable network visibility and high-fidelity threat detection to enterprise security teams around the world. SSP prioritizes advanced detection – using machine learning and statistical anomaly detection, advanced heuristics, and more traditional signature and IoC based detection – with explainable attack timelines. Its transparency, openness and extensibility empower security teams to quickly respond to serious threats and unauthorized activity.
“As a pure-play NDR solution vendor, we are uniquely focused on delivering the best threat detection possible with the lowest rate of false positives in the industry, enabling organizations to automate their response to serious and imminent threats,” said Stamus Networks CEO Ken Gramley. “We take great pride in being recognized by Gartner, once again, and believe our inclusion in this report is validation of our approach to helping defenders around the world secure their organizations.”
Learn more and download the Gartner “Market Guide for Network Detection and Response.”
To learn more about SSP, go to: https://www.stamus-networks.com/stamus-security-platform.
Gartner Disclaimer:Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
About Stamus Networks:Stamus Networks believes in a world where defenders are heroes, and a future where those they protect remain safe. As organizations face threats from well-funded adversaries, we relentlessly pursue solutions that make the defender’s job easier and more impactful. The global leader in Suricata-based network security solutions, Stamus Networks helps enterprise security teams know more, respond sooner and mitigate their risk with insights gathered from cloud and on-premise network activity. Our Stamus Security Platform combines the best of intrusion detection (IDS), network security monitoring (NSM), and network detection and response (NDR) systems into a single solution that exposes serious and imminent threats to critical assets and empowers rapid response. For more information visit: stamus-networks.com.
Logo – https://mma.prnewswire.com/media/1781381/stamus_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/stamus-networks-recognized-in-2024-gartner-market-guide-for-network-detection-and-response-302133899.html
Artificial Intelligence
StrongDM Secures $34 Million Series C Funding to Expand into Europe and Asia, and Establish Zero Trust PAM for Enterprise Security
New funding to fuel global expansion and a pioneering approach to preemptive, action-based cybersecurity
PALO ALTO, Calif., May 2, 2024 /PRNewswire/ — StrongDM, the Zero Trust privileged access company, today announced the closure of a $34 million Series C funding round led by Anchor Capital, with participation from new investors Capital One Ventures, Cisco Investments, Frontline Ventures, and Singtel Innov8, as well as existing investors including GV, Sequoia Capital, and True Ventures. This investment underscores StrongDM’s commitment to reshaping enterprise security with its revolutionary Zero Trust privileged access management (PAM) solution. The Series C funding round brings StrongDM’s total funding to $96 million.
Revolutionizing PAM
StrongDM introduces a next-generation PAM solution that shifts from traditional role- or attribute-based security models to one that emphasizes continuous, fine-grained, and context-aware policy enforcement. This approach scrutinizes each user action and context in real-time, enabling immediate blocking or additional verification for activities that pose security risks. By focusing on preemptive measures rather than reactive responses, StrongDM aims to halt breaches as they are attempted, setting a new standard in cybersecurity.
Global Expansion and Innovation
With the new funds, StrongDM will expand its operations into the Europe, Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions, addressing the growing demand for modern security solutions. The company is also establishing an engineering center of excellence in Poland, bringing its innovations closer to global customers.
A Word from Leadership
Tim Prendergast, chief executive officer of StrongDM, emphasizes the transformative nature of its Zero Trust PAM solution: “Our Zero Trust approach extends beyond initial access, offering continuous protection throughout the entire session. This isn’t just about reducing identification times; it’s about preventing breaches before they even happen. We’re setting new standards that legacy access management providers have failed to achieve over the past decade.”
Enhancing Enterprise Operations
StrongDM’s solution integrates security directly into operational workflows, enhancing agility and productivity without sacrificing protection. Amol Kabe, chief product officer of StrongDM, said: “StrongDM provides a way for users to create and apply policies that govern authorization in real time, which simplifies the process of proving regulatory compliance. By integrating comprehensive audit trails, we ensure that every action is recorded with precision. This provides unprecedented oversight and enforcement of security policies, creating an environment that is simple, agile, and secure.”
Kabe adds, “StrongDM can also trigger policy-based MFA or administrator-defined workflows natively or in Slack or ServiceNow to implement multi-party authorization for risky actions.”
Upcoming Features
In the coming months, StrongDM will roll out advanced policy-based control features that further enhance security for critical infrastructure. These include micro-authorizations and contextual enforcement capabilities designed to meet the specific needs of CISOs and security teams.
About StrongDM
StrongDM is at the forefront of cybersecurity, specializing in Zero Trust Privileged Access Management (PAM). Our innovative solutions focus on continuous, policy-based controls that leverage actions and context to enhance enterprise security. StrongDM’s technology scrutinizes each interaction in real time, preventing breaches before they occur and ensuring secure, frustration-free access across all platforms.
Supported by leading investors, including GV, Sequoia Capital, True Ventures, and Anchor Capital, StrongDM operates across North America, Europe, and Asia-Pacific, dedicated to setting new standards in cybersecurity and providing top-tier protection for today’s digital enterprises.
For more information, visit the StrongDM website.
Logo – https://mma.prnewswire.com/media/2402887/StrongDM_logo3000_cmyk_Logo.jpgPhoto – https://mma.prnewswire.com/media/2402888/Tim_Prendergast___CEO___StrongDM.jpg
View original content:https://www.prnewswire.co.uk/news-releases/strongdm-secures-34-million-series-c-funding-to-expand-into-europe-and-asia-and-establish-zero-trust-pam-for-enterprise-security-302133665.html
-
Artificial Intelligence6 days ago
Hikvision redefines urban mobility with AIoT-powered solutions at Intertraffic 2024
-
Artificial Intelligence6 days ago
HITACHI ACQUIRES MA MICRO AUTOMATION OF GERMANY IN EFFORT TO ACCELERATE GLOBAL EXPANSION OF ROBOTIC SI BUSINESS IN THE MEDICAL AND OTHER FIELDS
-
Artificial Intelligence6 days ago
Web O.No: Metaverse and Web 3.0 stunted by internet chaos, warn 87% of business leaders
-
Artificial Intelligence6 days ago
Greater efforts urged on sci-tech cooperation
-
Artificial Intelligence5 days ago
Cognitive Security Market Projected to Reach $134.26 billion by 2030 – Exclusive Report by 360iResearch
-
Uncategorized6 days ago
Xiao-I Corporation to Announce Full Year 2023 Results
-
Artificial Intelligence6 days ago
IBM, Government of Canada, Government of Quebec Sign Agreements to Strengthen Canada’s Semiconductor Industry
-
Uncategorized6 days ago
Damstra targets global growth as part of Ideagen